Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Randomized Phase II Trial of Captem or Folfiri As Second-Line Therapy in Neuroendocrine Carcinomas

Alberto Bongiovanni,Chiara Liverani,Flavia Foca,Francesca Bergamo,Silvana Leo,Sara Pusceddu,Fabio Gelsomino,Maria Pia Brizzi,Giovanni Di Meglio,Francesca Spada,Stefano Tamberi,Ivan Lolli,Mauro Cives,Riccardo Marconcini,Francesca Pucci,Rossana Berardi,Lorenzo Antonuzzo,Giuseppe Badalamenti,Daniele Santini,Federica Recine,Silvia Vanni,Michela Tebaldi,Stefano Severi,Britt Rudnas,Oriana Nanni,Nicoletta Ranallo,Laura Crudi,Luana Calabro,Toni Ibrahim

EUROPEAN JOURNAL OF CANCER（2024）

Cited 1|Views28
Key words
Neuroendocrine carcinomas (NECs),Phase II trial,Folfiri,Captem,Circulating miRNA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined